MedTrace Logo

Serum Sample Collection to Determine Analytical Performance Characteristics of the ADVIA Centaur PAPPA and BhCG Assays

NCT03629795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-08-14

No results posted yet for this study

Summary

Blood samples collected will be shipped to the sponsor's laboratory to establish analytical performance characteristics of the ADVIA Centaur® Pregnancy Associated Plasma Protein A (PAPP-A) and ADVIA Centaur® Free Beta Human Chorionic Gonadotropin (Free βhCG) assays.

Conditions

  • Trisomy 21 in Fetus
  • Trisomy 18 in Fetus
  • Trisomy 13 in Fetus

Sponsors & Collaborators

  • The Clinical Trial Company

    collaborator INDUSTRY

  • Axis Shield Diagnostics Ltd

    lead INDUSTRY

Principal Investigators

  • Stephen Robson · Professor of Fetal Medicine

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-17
Primary Completion
2018-01-24
Completion
2018-01-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03629795 on ClinicalTrials.gov